Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections.
JIA splint
Joint injection
Knee injection
Oligoarticular juvenile idiopathic arthritis
Journal
Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897
Informations de publication
Date de publication:
12 Jul 2019
12 Jul 2019
Historique:
received:
01
02
2019
accepted:
12
06
2019
entrez:
14
7
2019
pubmed:
14
7
2019
medline:
22
1
2020
Statut:
epublish
Résumé
Intraarticular corticosteroid injection (IACI) is one of the most common treatments in oligoarticular Juvenile Idiopathic Arthritis (JIA). Activity recommendations following injection vary, as there are no published studies on splinting JIA patients post-IACI (splinting is a form of rest). Texas Scottish Rite Hospital for Children (TSRH) splints patients post-IACI for 24 h while The Children's Hospital of Philadelphia (CHOP) does not. The aim of this study was to compare the number of cases of recurrent arthritis following IACI between these two post-injection practices. Data were retrospectively collected at CHOP and TSRH. Patients diagnosed with oligoarticular JIA according to International League of Associations for Rheumatology (ILAR) criteria (2nd revision, 2001) between 2008 and 2010 were included. Bivariate analysis (Wilcoxon rank-sum tests, chi-squared tests) was run to assess differences in outcomes by site. Inverse probability of treatment weighted Cox regression was employed to adjust for site differences. The population at TSRH was younger than at CHOP (p < 0.05) and had more whites (p = 0.03). Disease duration was significantly longer at TSRH than at CHOP (0.40 vs. 0.74 years, p = 0.014). More children were on biologics at the time of injection at CHOP (p < 0.05). The baseline physician global (p < 0.001) was higher at CHOP, as was the joint disease severity (p < 0.001). CHOP had fewer reoccurrences of knee arthritis compared to TSRH: 26% vs 38% (p = 0.14). The baseline populations were different in that the TSRH group had more whites and Hispanics, were younger and, perhaps, had less severe disease than CHOP. Patients treated with post-injection splinting had a trend toward more arthritis reoccurrence (38% vs. 26%, p = 0.14). Splinting is not clearly beneficial post-injection. This is an observational study, so it is not applicable.
Sections du résumé
BACKGROUND
BACKGROUND
Intraarticular corticosteroid injection (IACI) is one of the most common treatments in oligoarticular Juvenile Idiopathic Arthritis (JIA). Activity recommendations following injection vary, as there are no published studies on splinting JIA patients post-IACI (splinting is a form of rest). Texas Scottish Rite Hospital for Children (TSRH) splints patients post-IACI for 24 h while The Children's Hospital of Philadelphia (CHOP) does not. The aim of this study was to compare the number of cases of recurrent arthritis following IACI between these two post-injection practices.
METHODS
METHODS
Data were retrospectively collected at CHOP and TSRH. Patients diagnosed with oligoarticular JIA according to International League of Associations for Rheumatology (ILAR) criteria (2nd revision, 2001) between 2008 and 2010 were included. Bivariate analysis (Wilcoxon rank-sum tests, chi-squared tests) was run to assess differences in outcomes by site. Inverse probability of treatment weighted Cox regression was employed to adjust for site differences.
RESULTS
RESULTS
The population at TSRH was younger than at CHOP (p < 0.05) and had more whites (p = 0.03). Disease duration was significantly longer at TSRH than at CHOP (0.40 vs. 0.74 years, p = 0.014). More children were on biologics at the time of injection at CHOP (p < 0.05). The baseline physician global (p < 0.001) was higher at CHOP, as was the joint disease severity (p < 0.001). CHOP had fewer reoccurrences of knee arthritis compared to TSRH: 26% vs 38% (p = 0.14).
CONCLUSIONS
CONCLUSIONS
The baseline populations were different in that the TSRH group had more whites and Hispanics, were younger and, perhaps, had less severe disease than CHOP. Patients treated with post-injection splinting had a trend toward more arthritis reoccurrence (38% vs. 26%, p = 0.14). Splinting is not clearly beneficial post-injection.
TRIAL REGISTRATION
BACKGROUND
This is an observational study, so it is not applicable.
Identifiants
pubmed: 31299977
doi: 10.1186/s12969-019-0339-0
pii: 10.1186/s12969-019-0339-0
pmc: PMC6626321
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Triamcinolone Acetonide
F446C597KA
triamcinolone hexacetonide
I7GT1U99Y9
Types de publication
Comparative Study
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
42Références
J Rheumatol. 1999 Sep;26(9):2036-8
pubmed: 10493688
Arthritis Rheum. 1999 Nov;42(11):2330-4
pubmed: 10555028
J Rheumatol. 2000 Nov;27(11):2696-702
pubmed: 11093456
J Rheumatol. 2001 Sep;28(9):2100-2
pubmed: 11550981
Clin Exp Rheumatol. 2002 Sep-Oct;20(5):719-22
pubmed: 12412208
Arch Dis Child. 2003 Mar;88(3):192-6
pubmed: 12598375
Rheumatology (Oxford). 2003 Oct;42(10):1254-9
pubmed: 12810938
Ann Rheum Dis. 2003 Oct;62(10):1013-5
pubmed: 12972485
J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
Rheumatology (Oxford). 2004 Oct;43(10):1288-91
pubmed: 15252213
J Rheumatol. 2004 Nov;31(11):2290-4
pubmed: 15517647
J Rheumatol. 2004 Dec;31(12):2507-12
pubmed: 15570659
Ann Rheum Dis. 2005 Dec;64(12):1750-3
pubmed: 15843449
JAMA. 2005 Oct 5;294(13):1671-84
pubmed: 16204667
Indian Pediatr. 2008 Dec;45(12):995-7
pubmed: 19129569
Indian Pediatr. 2009 Mar;46(3):264-5
pubmed: 19346579
Rheumatol Int. 2011 Jun;31(6):749-56
pubmed: 20155422
Eur J Pediatr. 1991 Jan;150(3):170-2
pubmed: 2044586
Arthritis Care Res (Hoboken). 2010 May;62(5):735-7
pubmed: 20461791
J Rheumatol. 2012 Feb;39(2):374-6
pubmed: 22133622
Arthritis Care Res. 1990 Jun;3(2):103-4
pubmed: 2285741
Arthritis Care Res (Hoboken). 2013 Jul;65(7):1112-20
pubmed: 23335483
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Rev Bras Reumatol. 2016 Jan 24;:null
pubmed: 26970894
Open Access Rheumatol. 2009 May 14;1:37-49
pubmed: 27789980
AIDS. 2017 Jul 1;31 Suppl 3:S267-S275
pubmed: 28665885
Arthritis Rheum. 1986 Aug;29(8):997-1001
pubmed: 3741522
Br Med J. 1979 Apr 14;1(6169):986-7
pubmed: 435953
Acta Paediatr. 1993 Dec;82(12):1072-4
pubmed: 8155930
Br J Rheumatol. 1994 May;33(5):464-8
pubmed: 8173852
J Rheumatol. 1995 Sep;22(9):1631-5
pubmed: 8523335
J Rheumatol. 1996 Sep;23(9):1666-7
pubmed: 8877945
Arthritis Rheum. 1998 Jul;41(7):1210-4
pubmed: 9663477